1. Pink Sheet
  2. >>Geography
  3. >>Europe

‘Open & Constructive’: Early Feedback Supports Simultaneous Scientific Advice In Europe

16 Meetings Have Taken Place So Far

 
• By Neena Brizmohun

A European pilot project that lets drug companies developing innovative products receive scientific advice from two EU member states at the same time is proving its worth during the pandemic.

Train_Tracks
The SNSA pilot can help identify divergent regulatory opinions early on • Source: Shutterstock

Initial experience from a pilot project that provides drug developers with a one-stop shop for seeking scientific advice simultaneously from two EU members states has shown that the concept is working well and can be particularly useful during an emergency such as the COVID-19 pandemic.

A total of 16 simultaneous national scientific advice (SNSA) meetings have taken place for innovative products under development since the...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Europe

More from Geography

New EFPIA President Hopes ‘Sanity Will Prevail’ In EU Pharma Reform Dialogs

 
• By Eliza Slawther

Stefan Oelrich, the newly-announced president of European pharma industry federation EFPIA says the EU pharma reform is “not an improvement on the status quo” in its current form.

UK Pilots Faster Setup Of Early Phase Oncology Trials

 
• By Vibha Sharma

Oncology trial sponsors in the UK are being invited to participate in a pilot that aims to tackle duplication and variation in pharmacy reviews, which are an important part of setting up clinical trials in the National Health Service.

US CDC Vaccine Committee Revives Thimerosal Debate: A Portent Of Things To Come?

 
• By Bridget Silverman

The new Advisory Committee on Immunization Practices voted for new recommendations on the decades-old thimerosal safety issue and lays intellectual groundwork to revisit other past controversies and decisions.